Clinical Trial

Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

Study acronym: CARRISMM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-10-26; most recent amendment 2024-03-05.
Status change: Recruiting → Active, Not Recruiting 2024-03-05
Status change: Not Yet Recruiting → Recruiting 2020-07-27
Trial Details
NCT Number NCT04144387
Lead Sponsor Intergroupe Francophone du Myelome
Conditions Smoldering Multiple Myeloma
Enrollment 395 participants
Start Date 2020-02-11
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-03-06